Introduction:
Toxoplasmosis is a parasitic infection cause by Toxoplasma gondii. This parasite is associated with congenital infection and can cause abortion, encephalitis or systemic infection in immune- compromised patients.
Jundishapur Journal of Microbiology
Ahvaz Jundishapur University of Medical Sciences
Authors
Toxoplasmosis is a parasitic infection cause by Toxoplasma gondii. This parasite is associated with congenital infection and can cause abortion, encephalitis or systemic infection in immune- compromised patients.
In this study, two cases of central nervous system toxoplasmosis in leukemia patients are reported. The first case was a 15-year-old girl with acute lymphoblastic leukemia (ALL) who was using maintenance treatment for one year. The patient referred in 2010 to the hospital with headache, nausea and vomiting since three weeks ago. Brain magnetic resonance imaging (MRI) indicated a hypointense lesion in the left temporal compatible with cerebral toxoplasmosis. Serum immunoglobulin M (Ig M) rate against Toxoplasma was 8 and Ig G was 5 IU/mL. The patient was prescribed with pyrimethamin, sulfadiazine and lecoverin, but she was expired eight months after toxoplasmosis infection with bone marrow relapse in re- induction period of chemotherapy. The second case was a 6-year-old boy with acute myeloblastic leukemia (AML) diagnosed in 2010. The patient was on maintenance treatment. Two months ago, he was admitted to a hospital because of high temperature. In the brain MRI a 30 mm mass was revealed. Ig M antibody was more than 9 and Ig G was 6 IU/mL. The patient received pyrimethamin, sulfadiazine and leucoverin. He is alive and has the neurologic sequel.
Disseminated toxoplasmosis is a major health problem in immune- compromised patients, and it is necessary to examine the patients before, during and after chemotherapy for toxoplasmosis.
Implication for health policy/practice/research/medical education:Disseminated toxoplasmosis is a major health problem in immune- compromised patients, and it is necessary to examine the patients before, during and after chemotherapy for toxoplasmosis.
Authors’ Contribution:None declared.
Financial disclosure:The authors declare no financial disclosure.
Funding/Support:None declared.
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Abolghasemi H, Shahverdi E, Jafari R, Dolatimehr F, Khandani A. Central Nervous System Toxoplasmosis in Relapsed Hodgkin’s Lymphoma: A Case Report. Int J Cancer Manag. 2016;9(4):e5810. doi: https://doi.org/10.17795/ijcp-5810
Arab-Mazar Z, Zamanian MH, Yadegarynia D. Cerebral Toxoplasmosis in an HIV-Negative Patient: A Case Report. Arch Clin Infect Dis. 2016;11(1):e30759. doi: https://doi.org/10.5812/archcid.30759
Baratloo A, Hashemi B, Rouhipour A, Haroutunian P, Mahdlou M. Review of Toxoplasmic Encephalitis in HIV Infection; a Case Study. Arch Neurosci. 2015;2(2):e20891. doi: https://doi.org/10.5812/archneurosci.20891
Barazesh A, Sarkari B, Mehrabi Sisakht F, Abdolahi Khabisi S, Nikbakht R, et al. Seroprevalence and Molecular Evaluation of Toxoplasmosis in Patients Undergoing Chemotherapy for Malignancies in the Bushehr Province, Southwest Iran. Jundishapur J Microbiol. 2016;9(9):e35410. doi: https://doi.org/10.5812/jjm.35410
Sayyahfar S, Karimi A, Gharib A, Fahimzad A. Association of Systemic Anaplastic Large Cell Lymphoma and Active Toxoplasmosis in a Child. Int J Cancer Manag. 2015;8(4):e3438. doi: https://doi.org/10.17795/ijcp-3438
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 20 hours ago